• Bridgepoint in connection with :
  • the acquisition of the Equativ group;
  • the acquisition of the Sinari group.
• The Carlyle Group in connection with various private equity transactions, including:
  • the acquisition of the Lacour Group;
  • its investment in Neverhack.
• L-Gam on its investment in the Biose group.
• The Management of Sagemcom group in connection with the acquisition of a majority stake by Charterhouse
• Siparex and EMZ Partners on their investment in Batibig
• Bpifrance, alongside Tikehau Capital and Tikehau Ace Capital, on its investment in ChapsVision, a French data platform provider.
• Trail in connection with various private equity transactions, including:
  • the sale of the Sepur group; and
  • the acquisition of Electropoli.
• Mubadala in its investment in SGD Pharma alongside PAI Partners.
• Bpifrance in the context of a subscription to a capital increase of Matera (Series B).
• Mubadala and Bpifrance on their investment in Omni-Pac Group alongside the Latour Capital and the target's managers.
• HalioDx and its shareholders on the sale of HalioDx to Veracyte, Inc.
• Florac in connection with various private equity transactions, including:
  • its investment in Salto;
  • its investment in the Sani and Ikos resorts alongside Oaktree (Greece and Spain);
  • its investment in Samson & Surrey (U.S.);
  • its investment in GrandiStazioni (Italy);
  • its investment in Les Domaines de Fontenille ;
  • its investment in Padi (U.S.); and
  • its acquisition and subsequent sale of BricoPrivé.
• LBO France in connection with:
  • its acquisition of Dutscher group; and
  • the implementation of an impact debt for Moustache Bikes.
• Siparex in connection with various private equity transactions, including:
  • its acquisition of NG Travel; and
  • its investment in Batibig Group.
• Constellium SE on the transfer of its headquarters from Amsterdam to Paris.
• CCI Lyon Metropole in connection with the investment by Qualium Investissement and Bpifrance in Emlyon.
• The lenders in connection with the senior financing in support of the €3.1 billion public to private acquisition of Iliad Group by Xavier Niel, the founder and current controlling shareholder of the Group.
• Nokia in the sale of its Digital Health business.
• Unibail-Rodamco on its $25 billion acquisition of Westfield Corporation.
• The shareholders of French Medtech company IMASCAP in connection with its 100% sale to U.S. global medical device company Wright Medical.
• Orange in the sale of approximately 133 million shares in BT for an amount of GBP 383 million and the issuance of bonds exchangeable into BT shares for an amount of approximately GBP 520 million.
• Alstom in connection with the carve-out and sale of its Power & Grid activities to General Electric.
• EFG Hermes on acquisition of EDP Renewables France.
• The Coca-Cola Company, Altice, and Schneider Electric in connection with various tax matters.
• Various listed and non-listed companies in connection with international employee incentive plans (including notably international stock-options plans or free share plans).

Matters may have been handled prior to joining Paul Hastings.

• Member, Paris Bar